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Abstract
Increasing importance is being placed on the role of drug solubilisation in the drug development pipeline. In order 
for drugs to successfully pass through the pre-clinical studies required before clinical trials they often require addition 
of excipients or solubility modifying agents. This study highlights the use of sulfonated calix[4]resorcinarenes as drug 
solubilising agents. The rigid nature of these compounds form cone-like structures with hydrophobic interiors which are 
capable of accommodation of hydrophobic entities such as drugs. The calix[4]resorcinarenes in this work have varied 
length of alkyl chains attached to their lower rim. This work investigated the effect of chain length (C = 4 (SC(4)RC4), 
C = 7 (SC(4)RC7)) on the degree of solubilisation of two model hydrophobic drugs: propofol and griseofulvin. The 
data showed that the compounds were capable of solubilising both drugs up to 8 mgmL-1 (SC(4)RC7-propofol) and 3 
mgmL-1 (SC(4)RC4-griseofulvin). The size measurements carried out using photon correlation spectroscopy indicated 
that the SC(4)RC4 was likely to form 1:1 interactions with drug molecules whilst the SC(4)RC7 formed supramolecular 
structures capable of increased drug loading in the case of propofol. In the case of griseofulvin it is postulated that 
similar structures were formed however these exceeded the limit of the filter used and may have been lost. Additionally, 
the supramolecular structures appeared more stable with a reduction in drug release. In vitro testing on BxPC-3 cells 
indicated that the calix[4]resorcinarenes were relatively non-toxic. These studies highlight the potential of these systems 
in drug delivery.
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Introduction 
Over the past few decades, the development of solubilisers for 
hydrophobic drugs as drug delivery systems has attracted much 
attention among researchers in both pharmaceutical and biomedical 
fields [1,2]. More than 40% of therapeutic agents identified in 
combinatorial libraries are classified as hydrophobic [3]; in the 
UK drugs which possess aqueous solubility below 0.1 mgmL-1 at 
25°C are classed as practically insoluble according to the British 
Pharmacopoeia [4]. Such drugs which exhibit poor physicochemical 
properties may be significantly limited in their progress through the 
drug discovery pipeline. Particularly importantly are those drugs 
which show promising clinical relevance which may suffer from low 
bioavailability as a result of their inability to dissolute into aqueous 
media before further absorption. Formulation strategies are thus 
required to overcome these issues and improve drug efficacy and 
efficiency. It is well recognised that commonly used excipients possess 
undesirable properties in terms of their viscosity, excipient to drug 
rations required for drug solubilisation and their stability in aqueous 
media. Hence, novel technologies for drug solubilisation are required 
which can increase drug solubilisation and overcome the issues of 
traditional excipients. Calix[n]arenes are one such technology which 
hold potential as drug solubilisers due to their conformation and ability 
to form complexes with drug molecules.
Calix[n]arenes have been studied extensively as host molecules in 
supramolecular chemistry [5]. Derived from phenols, they are cyclic 
oligomers which can be envisaged as cone-shaped molecules with 
a hydrophobic interior. Calix[n]arenes themselves are inherently 
hydrophobic but possess an upper- and lower-rim which may be 
functionalised readily to modify their properties (Figure 1a). Calix[4]
resorcinarenes are related to the calix[n]arenes in that they can also 
possess a cone-shaped structure with a hydrophobic interior and an 
upper- and lower rim [6] (Figure 1b). However, since resorcinol 
will react with a wide range of aldehydes under the conditions 
required for their synthesis, an extensive library of structurally 
diverse calix[4]resorcinarenes exists. The calix[4]resorcinarenes have 
found widespread use in host-guest and supramolecular chemistry, 
exemplified in the synthesis of cavitands and carceplexes [7,8]. They 
have been demonstrated to form stable complexes with small molecular 
species but notably the majority of these studies have been undertaken 
in non-polar media - which would not be suitable for drug delivery 
applications.
Of the few examples in the literature, structurally modified calix[n]
arenes have been shown to form stable complexes with small molecular 
species in aqueous media. In particular, there is an established evidence 
base confirming that water-soluble calix[n]arenes which possess 
sulfonate groups in the 4-position on the upper rim are capable of 
solubilising drug molecules which otherwise possess poor solubility in 
aqueous media [9-21]. However, few investigations into the properties 
and utility of simple calix[4]resorcinarenes which bear sulfonate 
groups in the 2-position on the upper rim have been reported.
Kazakova et al. first reported the synthesis of three sulfonated 
calix[4]resorcinarenes and their formation of 1:1 complexes with amino 
acids in aqueous media [22]. The group later reported a comparative 
study into the interactions of sulfonated calix[4]resorcinarenes bearing 
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alkyl chains of either 1 carbon (methyl group) or 5 carbons (pentyl) on 
the lower rim with small molecules capable of multiple non-covalent 
interactions in aqueous media [23]. This study presented evidence 
that sulfonated calix[4]resorcinarenes are able to aggregate with the 
hydrophobic pentyl moieties entering the hydrophobic inner core of 
neighbouring calyxes even in the presence of small molecular guests. 
More recently, Menon has reported detailed studies into the use of a 
sulfonated calix(4)resorcinarene derived from acetaldehyde for the 
solubilisation of pharmaceutical agents mycophenolate mofetil [24] 
and lamotrigine [25].
In this study two sulfonated calix[4]resorcinarenes which have 
alkyl chains on the lower rim of varied length (4 & 7 carbon) are 
compared for their ability to act as drug solubilisers. The chemical 
structure of the butylated (4 carbon) calix(4)resorcinarene (SC(4)
RC4) and the heptylated (7 carbons) calix(4)resorcinarene (SC(4)RC7) 
are shown in Figure 2a. The potential of SC(4)RC4 and SC(4)RC7 as 
drug solubilisers is investigated using two model hydrophobic drug 
molecules: propofol and griseofulvin. Propofol (2,6-diisopropylphenol) 
(Figure 2b) is a commonly used anaesthetic, licensed for both induction 
and maintenance of anaesthesia [26,27]. Due to its poor solubility in 
aqueous media (100 μgmL-1 at 25°C), propofol is currently formulated 
in soybean oil (100 mgmL-1) forming an oil-in-water emulsion [26]. 
Despite the market success of propofol emulsions, the concomitant use 
of painkillers and antimicrobial agents are required due to its viscosity 
causing pain on administration and the high infection risk [28]. 
Additionally, hyperlipidemia, rhabdomyosis and metabolic acidosis 
have been reported and linked to propofol-fat parental emulsions 
(propofol-Related Infusion Syndrome) [29]. Griseofulvin ((2S)-trans-
7-chloro-2’,4,6-trimethoxy 6’-methylspiro(benzofuran-2[3H],1’-[2] 
cyclohexene)3,4’-dione) (Figure 2c) is an orally administered anti-
fungal agent, used for the treatment of dermatophytoses. The high 
degree of lipophilicity of griseofulvin (aqueous solubility of 30 
μgmL-1 at 25ºC), results in long dissolution rates and consequently 
poor bioavailability in the GI tract [30]. Significant intersubject and 
intrasubject variations in bioavailability have also been reported, not 
only between different branded preparations but also between different 
physiological stages of the stomach, indicating clinical failure with 
griseofulvin therapy in most patients [31]. Moreover, a dosing regime 
is difficult to be established considering fluctuations in the drug’s 
bioavailability profile as it is currently formulated.
Materials and Methods
All materials were purchased from Sigma Aldrich (UK) unless 
otherwise stated.
Synthesis of sulfonated calix[4]resorcinarenes 
Sulfonated calix[4]resorcinarenes SC(4)RC4 and SC(4)RC7 were 
prepared from the parent calix[4]resorcinarenes C(4)RC4 and C(4)
RC7 using established procedures [22,32]. In brief, concentrated 
hydrochloric acid (12.5 mL) was added dropwise to a solution of either 
n-pentanal (for C(4)RC4) or n-octanal (for C(4)RC7) (90 mmol) and 
resorcinol (90 mmol) in ethanol (75 mL). In each case the mixture 
was heated to reflux for 4 h and then allowed to cool to ambient 
temperature. The product precipitated upon cooling. Water (50 mL) 
was added slowly to the cooled mixture to complete the precipitation. 
The crude products were isolated by vacuum filtration and recrystallized 
from ethanol to give C(4)RC4 (yield 85%) and C(4)RC7 (yield 78%) as 
colourless solids.
C(4)RC4 or C(4)RC7 (0.01 mol), formaldehyde (37% solution, 
0.05 mol) and sodium sulfite (0.05 mol) were combined with water (30 
mL) and the stirred mixture was heated at 90°C for 16 h. The mixture 
was cooled to ambient temperature. Dilute hydrochloric acid (1 molar 
aqueous solution) was added to the cooled mixture until pH 7 was 
reached. Acetone (~50 mL) was added to the mixture to precipitate 
sulfonated calix(4)resorcinarene. The precipitate was isolated by 
filtration, washed with acetone on the filter and then dried under 
vacuum to give SC(4)RC4 (yield 53%) and SC(4)RC7 (yield 85%) as 
yellow solids.
Chemical characterisation of calix[4]resorcinarenes
1H Nuclear Magnetic Resonance (NMR) spectra of SC(4)RC4 and 
SC(4)RC7 were acquired by making a solution of each compound 
in d6-dimethylsulfoxide (d6-DMSO) (Goss Scientific Instruments 
Limited) and irradiating the solutions at 400 MHz using a Bruker 
DMX-400 NMR instrument.
FTIR was carried out on solid powder samples of SC(4)RC4 and 
SC(4)RC7 using a NICOLET iS5 fitted with a iD5 ATR laminated 
diamond crystal tip (Thermo Scientific™, UK). The average spectra of 
64 scans was recorded.
Physical characterisation of calix[4]resorcinarenes in 
aqueous phase
The surface activity of SC(4)RC4 and SC(4)RC7 was determined 
by measurement of surface tension using a torsion balance (OS 
Instruments). Solutions of SC(4)RC4 and SC(4)RC7 were prepared 
over a concentration range 0.039 mgmL-1 - 5mgmL-1 in deionised 
water. Samples were probe sonicated for 5minutes using a Soniprep 
150 (MSE Ltd, UK). The samples were coolied to room temperature, 
and the surface tension measured. Measurements were conducted in 
triplicate for each sample, and an average value was obtained over three 
independent samples.
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Figure 1: General structures of A) a calix[n]arene and B) a calix[4]resorcinarene.
Figure 2:  Structures of A) SC(4)RC4 (R = C4H11) and SC(4)RC7 (R = C7H15), B) 
propofol and C) griseofulvin.
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The hydrodynamic diameter and polydispersity index (PDI) was 
measured using photon correlation spectroscopy (Zetasizer Nano-
ZS, Malvern Instruments, UK). Aqueous solutions of SC(4)RC4 and 
SC(4)RC7 (1mgmL-1) were probe sonicated for 5 mins and once cooled 
were filtered using a 0.45 μm syringe filter. The mean particle size and 
PDI values were attained by averaging values of three measurements. 
Samples were measured at 24.9oC and pH 7. 
Drug incorporation studies
Solutions of SC(4)RC4 and SC(4)RC7 at varied concentration 
(1 mgmL-1, 3 mgmL-1 and 6 mgmL-1) were prepared in deionised 
water and probe sonicated for 10 min. Samples were cooled to room 
temperature and the appropriate volume of drug was added in 1:1, 5:1 
and 10:1 initial drug: calixa(4)resorcinarene ratio. The solutions were 
probe sonicated for 5 min and allowed to cool to room temperature. 
The solutions were filtered using 0.45 μm syringe filter to remove any 
excess free drug. Drug quantification was carried out using UV-Vis 
spectroscopy (Cary 50 Bio, Agilent Technologies U.S). Propofol was 
quantified at 272 nm and griseofulvin at 242 nm. Calibrations were run 
of the free drugs dissolved in acetonitrile and methanol (propofol and 
griseofulvin respectively), both obtaining R2 of 0.999. The formulations 
were diluted in the appropriate solvent to liberate the free drug and 
enable measurement. Drug quantification was carried out in triplicate 
at room temperature.
Physical characterisation of formulations
Optimal formulations were measured for hydrodynamic radius as 
described above. The formulations were freeze dried and 64 scans run 
in order to qualitatively show drug presence as previously described.
In vitro drug release studies
Optimal formulation for each calix(4)resorcinarene and drug were 
dialysed against water to harness their drug release profile. Briefly, 
2 mL of formulation was pipetted inside a visking tube (12-14 kDa) 
(Medicell, UK) and dialysed against distilled water (200 mL) at room 
temperature. The volume of dialysis fluid was in excess to “mimic” the 
“in sink” conditions experienced after injection into the blood stream. 
A 2 mL sample of the exterior solution was obtained at selected time 
points (5 min, 10 min, 15 min, 20 min, 30 min, 40 min, 50 min and 
60 min) and replaced with deionised water. Drug quantification was 
carried out as previously described. All measurements were carried out 
in triplicate at room temperature.
Cytotoxicity of calix[4]resorcinarenes
An MTT assay was carried out using human pancreatic 
adenocarcinoma (BxPC-3) cells. Cells were cultured in RPMI medium 
containing 10% FBS and 1% penicillin streptomycin (Penstrep). Cells 
were subcultured into a 96-well plate at 15 million cells per well. SC(4)
RC4 and SC(4)RC7 of varied concentration (0.019 – 10 mgmL-1) were 
prepared in media. Once 80% confluency had been reached the cells 
were exposed to the calix[4]resorcinarenes (100 μL) for 24 h before 
being washed with fresh media (100 μL three times) and incubated for 
4 h with media (100 μL) and MTT solution (20 μL). The absorbance of 
the plate was read at 570 nm and cell viability was calculated relative to 
positive and negative controls.
Results and Discussion
Sulfonated calix[4]resorcinarenes SC(4)RC4 and SC(4)RC7 were 
characterised using 1H NMR spectroscopy and Fourier transform 
infrared spectroscopy. The 1H NMR spectrum of SC(4)RC4 was 
acquired as a solution in d6-DMSO and showed characteristic signals 
at 7.21 ppm (proton on a pentasubstituted aromatic ring) and 4.09 ppm 
(methylene group bridging two aromatic rings. Similarly, the 1H NMR 
spectrum of SC(4)RC7 as a solution in d6-DMSO and showed these 
characteristic signals at 7.30 ppm and 4.27 ppm, respectively (data not 
shown). This indicated that both compounds had adopted the crown 
conformation solely.
The FTIR spectra of SC(4)RC4 and SC(4)RC7 (Fig. 3A1 & B1) both 
show common peaks relating to the O-H stretch of the phenols between 
3500-3200 cm-1. Other peaks identified at 1585-1600 cm-1 were due to 
the C-C in the aromatic ring, further C=C stretches were also identified 
at 1400-1500 cm-1. It was difficult to distinguish between the samples 
to identify chain attachment, perhaps because detection of vibrational 
motions of the very restricted regions within a nano-scale sample is 
more likely to occur with a micro- FT-IR rather than a simple FTIR 
apparatus [33]. The peaks assigned to the alkyl C–C group, present in 
either stretching or bending bands are also possibly too weak or too low 
in frequency to be detected by IR spectroscopy. However, the spectra in 
combination with the 1H NMR indicate that the calix[4]resorcinarenes 
were successfully synthesised (Figure 3).
The surface activity of both SC(4)RC4 and SC(4)RC7 was determined 
via surface tension measurement in water (Figure 4). These studies can 
give an indication of supramolecular formation in bulk solution and 
are often used in polymer studies [34]. Calix[n]arenes themselves exist 
as rigid structures which does not require micellation or aggregation to 
occur to satisfy themselves stability wise in aqueous media. However, 
our calix[4]resorcinarenes possess hydrophobic chains on their lower 
rim which could give rise to aggregation due to reduction in Gibbs’ free 
energy. The short chained SC(4)RC4 did not appear to alter the surface 
tension of water at most of the concentrations tested (0.039 mgmL-1 – 
1.25 mgmL-1). However above these concentrations the surface tension 
of the water was reduced from 0.072 Nm-1 to 0.054 Nm-1. This suggests 
that the SC(4)RC4’s do not form aggregates and exit in a singular basis. 
The reduction of surface tension at higher concentrations may be due 
to location of these particulates in the bulk, whereby, at increased 
concentrations the particles are closer to each other and are forced 
to occupy the surface layer thus interfering with the natural surface 
tension of the water. The hydrodynamic diameter data for SC(4)RC4 
(Table 1) indicated that at all concentration ranges tested only one size 
population of approximately 78 nm was detected. The polydispersity 
index readings were also very low which indicated the samples were 
monodisperse. These finding are in agreement with the surface tension 
measurements suggesting that the short chained calix[4]resorcinarenes 
exist as individual entities in solution (Figure 5).
In contrast, the SC(4)RC7’s caused a reduction in the surface 
tension of water at low concentration (Figure 4). The point of 
inflexion in the surface tension graph is an indication of aggregation 
in the bulk solution, a technique often used in amphiphilic polymer 
characterisation to denote critical aggregation concentration. For 
SC(4)RC7 the surface tension graph showed two points of inflexion and 
hence two CAC’s were evident. In polymer chemistry this would suggest 
formation of both intramolecular and intermolecular aggregates [34]. 
However, as calix[4]resorcinarenes are not capable of intramolecular 
aggregation it is postulated that the first CAC at 0.0195 mgmL-1 is due 
to two particulates coming together with their lipiphilic chains forming 
weak hydrophobic-hydrophobic interactions (Figure 5). At increased 
concentrations, above the second CAC value (0.625 mgmL-1) larger 
supramolecular structures are likely to form, as groupings of increased 
number (three or more) of calix[4]resorcinarenes come together to 
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Figure 3: FTIR spectra of freeze dried calix[4]resorcinarenes / formulations. FTIR run using a diamond tipped ATR and run over 64 scans of A) SC(4)RC4 and B) SC(4)
RC7, 1) in the absence of drug and after complexation with 2) propofol and 3) griseofulvin.
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Particulate Concentration mgmL-1
Size nm (± SD): 
percentage 
occurrence
PDI (± SD)
SC[4]RC4
0.1 77 (3.43): 100% 0.123 (0.453)
1.0 78 (3.54): 100% 0.134 (0.065)
5.0 78 (2.54): 100% 0.111 (0.012)
SC[4]RC4-Propofol N/A 82 (4.22): 100% 0.211 (0.036)
SC[4]RC4-
Griseofulvin N/A 85 (2.32): 100% 0.152 \(0.333)
SC[4]RC7
0.1 92 (2.42): 100% 0.154 (0.091)
1.0 86 (4.32): 41%240 (2.31): 59% 0.345 (0.122)
5.0
89 (1.23): 20%
363 (3.34): 70%
5095 (12.74): 10%
0.564 (0.098)
SC[4]RC7-Propofol N/A 124 (1.23): 24%421 (6.88): 76% 0.434 (0.073)
SC[4]RC7-
Griseofulvin N/A
229 (5.43): 32%
473 (3.45) : 68% 0.345 (0.232)
Table 1: Hydrodynamic radius and polydispersity index of calix[4]resorcinarenes 
and optimal drug formulations. Samples recorded in triplicate at 25°C.
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shield their lipophilic tails from the ‘hostile’ aqueous environment. 
Particle size measurements showed that SC(4)RC7 forms particles with 
a diameter of 92 nm at a concentration of 0.01 mgmL-1 in water (Table 
1). However, in agreement with the surface tension findings, larger 
diameter species form at higher concentrations: at a concentration of 
1 mgmL-1 the dominant species being 240 nm which increases further 
at increased concentration 5 mgmL-1 the predominant species has a 
diameter of 363 nm. This indicates that supramolecular structures are 
indeed formed at these higher concentrations as discussed. 
The difference in these two calix[4]resorcinarenes is the length of 
their alkyl chains attached to their lower rim. It is therefore deduced 
that the short butyl chain with only four carbons does not possess the 
degree of hydrophobicity of the heptyl chain with seven carbons and 
hence the different mechanisms of solution existence and stabilisation.
Figure 6 shows the drug loading data for both SC(4)RC4 (A1&2) 
and SC(4)RC7 (B1&2) with propofol and griseofulvin compared 
with the intrinsic drug solubility. The study used varied excipient 
(calix(4)resorcinarene) concentration and initial drug:excipient 
feed concentration. In general all studies showed that increasing 
the excipient concentration resulted in increased drug loading. 
Additionally, the drug feed ration impacted drug incorporation with 
increased feed ratios increasing drug content. For the propofol studies, 
the SC(4)RC4 was capable of reduced drug solubilisation compared 
with the SC(4)RC7 as maximum concentrations of 4 mgmL-1 were 
achieved compared with 8.4 mgmL-1 respectively. Given the size 
and surface tension data, this result is rational based on the SC(4)
RC7 forming larger aggregates capable of drug solubilisation (Figure 
5). One of the perceived disadvantages to the use of calixarenes and 
calix[4]resorcinarenes is their rigid structure which can hinder drug 
incorporation. Often structures such as polymers can experience core 
expansion upon drug incorporation, however this is not likely to be 
possible for these rigid structures existing singularly. This is identified 
in the size data for SC(4)RC4-propofol formulation where the size 
is increased only marginally in the presence of drug. However, with 
the SC(4)RC7-propofol formulation, drug solubility was increased 
up to 84-fold compared to intrinsic levels. Here, the size data of the 
optimal formulation of SC(4)RC7-propofol (6 mgmL-1, 10:1) showed 
that core expansion had occurred with a noteable increase in core 
size compared with the empty vehicle. This may either be due to 
hydrophobic stabilisation of the lipophilic chains once drug is in 
the large core resulting in core expansion or the addition of further 
molecular units forming even larger supramolecules. This formation of 
stabilised supramolecular structures may increase applicability of such 
technologies to a wide range of drug molecules compared with the one-
to-one interaction of the SC(4)RC4.
Propofol is a small molecule and therefore, testing with a second 
more bulky drug molecule such as griseofulvin is advantageous. 
Griseofulvin incorporation did not follow the same trend, infact the 
short chained SC(4)RC4 was capable of incorporation of concentrations 
up to 3 mgmL-1 compared with only 0.75 mgmL-1 for the SC(4)RC7. 
Additionally, no significant difference was found between 3 mgmL-1 
and 6 mgmL-1 loading. The rationale for this is due to core expansion 
occurring. As mentioned griseofulvin is a bulky molecule and great 
steric hindrance would be experience whilst drug incorporation is 
occurring. In fact, visually before filtration the SC(4)RC7 appeared to 
have solubilised greater drug content compared with the SC(4)RC4. 
Therefore, it is postulated that the core expansion experienced with 
the longer lipophilic chains is such that the aggregates exceeded the 
maximum cut off for the 0.45 μm filter. Hence, the larger aggregates 
did not pass through resulting in this reduction of drug concentration. 
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In the case of griseofulvin, it is therefore more advantageous to use the 
one-to-one interaction of the short chain SC(4)RC4 (Figure 5). This 
work highlights the importance of looking at more than one excipient 
before final decision in drug solubilisation as in the case of these calix[4]
resorcinarenes universal drug solubilisation is not achieved with every 
vehicle and they are dependant on factors such as hydrophobicity, 
molecular weight and architecture of the drug being solubilised.
Numerous evidence suggests that drug release rate is driven by 
drugs’ intrinsic aqueous solubility [35-37]. A drug molecule with low 
aqueous solubility, denotes a highly hydrophobic molecule which will 
experience high affinity for the similarly hydrophobic core of calix[n]
arenes. Thus, a slow release profile will be expected. The release data 
for SC(4)RC4 support the above statement, as griseofulvin with 
significant lower aqueous solubility (0.03 mgmL-1) than propofol (0.1 
mgmL-1) shows a much lower release profile with only 15% being 
released after 1 h compared with 30% for propofol (Figure 6A3). 
Intrinsic hydrophobicity of nano-aggregates is also a determinant 
key in drug release rate. A notable lower drug release rate is observed 
when comparing SC(4)RC4 to SC(4)RC7 formulations. Consequently, 
propofol encapsulated in SC(4)RC4 with the shorter less lipophilic 
chain is released more rapidly (30% after 1 h) than when held in the more 
lipophilic supramolecular structure of the SC(4)RC7 (5% after 1 h) (Figure 
6A3 and B3). In several drug formulation studies, low and sustained drug 
release is favoured over rapid release due to significant advantages of the 
former including; reduced local toxicity and increased in vivo half life 
[36,37]. From this aspect, SC(4)RC7 may be more desirable than SC(4)
RC7 as this infers increased stability under sink conditions. 
In order for any drug delivery system to be clinically relevant it 
must itself be safe for administration. Therefore it is important to 
determine whether the empty vehicle exhibits any cytotoxic nature. 
This study was carried out on human pancreatic adenocarcinoma cell 
lines (BxPC-3) after exposure for 24 h. The data in Figure 7 shows that 
even up to extremely high (non clinically relevant) concentrations the 
calix[4]resorcinarenes remained relatively non-toxic. In fact, up to 
10 mgmL-1, an IC50 value (at which 50% of the cells were no longer 
viable) was not observed with the SC(4)RC7. In contrast the SC(4)
RC4 exhibited an IC50 at approximately 7.5 mgmL-1, however, this is 
extremely high compared with other excipients such as polymers [38]. 
The data is encouraging and shows the potential of these systems to not 
only carry drugs but to do so more safely and efficiently than traditional 
systems. Further biological work is required in order to fully appreciate 
their biosafety.
Conclusion
Both SC(4)RC4 and SC(4)RC7 have demonstrated to improve 
aqueous solubility of both hydrophobic drugs tested, suggesting 
the great potential of these molecules as novel drug solubilisers. 
Nonetheless, parameters affecting formation of inclusion complexes, 
not explored in this study need to be further investigated, including 
physical characteristics of aqueous environment (e.g. pH and 
temperature). Moreover, further toxicology, stability and in vivo 
studies need to be designed, to establish safety clinical relevance of 
these systems. 
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Figure 6:  Drug incorporation studies using A) SC(4)RC4 and B) SC(4)RC7 with 1) propofol and 2) griseofulvin. 3) In vitro drug release over 1 h. All experiments carried 
out at room temperature (n = 3, ± SD).
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Figure 7:  Cell viability of BxPC-3 cells after 24 h incubation with resorcinarenes 
measured via MTT assay at 570 nm.
